WE ARE FOLLOWING BREAKING NEWS RIGHT NOW AT 827. I’M ANTOINETTE ANTONIO. MASS. GENERAL BRIGHAM AND CAMBRIDGE BASED EGENESIS JUST ANNOUNCED THEY HAVE FDA APPROVAL TO LAUNCH A NATIONAL CLINICAL TRIAL FOR PIG KIDNEY TRANSPLANTS. THEY ALSO REVEALED MGH PERFORMED A THIRD TRANSPLANT OF GENETICALLY MODIFIED PIG KIDNEY INTO A HUMAN PATIENT IN JUNE. THAT
Man receives pig kidney in successful transplant, company says
![WMUR logo]()
Updated: 8:22 AM CDT Sep 8, 2025
Editorial Standards ⓘ
A New Hampshire man received a successful pig kidney transplant in June, a biotech company announced Monday.Bill Stewart, 54, received the kidney on June 14. He was discharged from Massachusetts General Hospital a week later, and today, he no longer requires dialysis.Stewart had been receiving dialysis three times a week for more than two years before the transplant, according to a news release from eGenesis, a biotech company based in Cambridge, Massachusetts.Stewart is the second person to receive a genetically engineered pig kidney, known as an EGEN-2784 kidney, through this eGenesis study.The first person to do so was also from New Hampshire. Tim Andrews, 67, of Concord, received his pig kidney on Jan. 25, 2025, and now, seven months post-transplant, he continues to live dialysis-free, the company said in a news release.Stewart and Andrews are the second and third people in the world to receive an EGEN-2784 kidney, according to the company.In announcing the second successful transplant through their study, eGenesis also revealed that the U.S. Food and Drug Administration cleared its investigational new drug application to start a clinical trial evaluating EGEN-2784 kidneys for patients with end-stage kidney disease.
MANCHESTER, N.H. — A New Hampshire man received a successful pig kidney transplant in June, a biotech company announced Monday.
Bill Stewart, 54, received the kidney on June 14. He was discharged from Massachusetts General Hospital a week later, and today, he no longer requires dialysis.
Stewart had been receiving dialysis three times a week for more than two years before the transplant, according to a news release from eGenesis, a biotech company based in Cambridge, Massachusetts.
Stewart is the second person to receive a genetically engineered pig kidney, known as an EGEN-2784 kidney, through this eGenesis study.
The first person to do so was also from New Hampshire. Tim Andrews, 67, of Concord, received his pig kidney on Jan. 25, 2025, and now, seven months post-transplant, he continues to live dialysis-free, the company said in a news release.
Stewart and Andrews are the second and third people in the world to receive an EGEN-2784 kidney, according to the company.
In announcing the second successful transplant through their study, eGenesis also revealed that the U.S. Food and Drug Administration cleared its investigational new drug application to start a clinical trial evaluating EGEN-2784 kidneys for patients with end-stage kidney disease.
